Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

By Sebban Catherine  

Supportive Care in Cancer, Vol. 16, Iss. 9, 2008-09 ,pp. : 1017-1023

Springer Publishing Company

Access to resources Recommend Favorite

Identification of High-Risk Groups among Node-Positive Patients with Stage IB and IIA Cervical Carcinoma

By Samlal R.A.K.   van der Velden J.   Schilthuis M.S.   Gonzalez D.G.   Ten Kate F.J.W.   Hart A.A.M.   Lammes F.B.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 463-467

Elsevier

Access to resources Recommend Favorite

Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence

By Saji Hisashi   Tsuboi Masahiro   Shimada Yoshihisa   Kato Yasufumi   Hamanaka Wakako   Kudo Yujin   Yoshida Koichi   Matsubayashi Jun   Usuda Jitsuo   Ohira Tatsuo   Ikeda Norihiko  

Oncology Reports, Vol. 29, Iss. 5, 2013-05 ,pp. : 1902-1906

Spandidos Publications

Access to resources Recommend Favorite

Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome: A controlled clinical study

By  

Experimental and Therapeutic Medicine, Vol. 8, Iss. 6, 2014-01 ,pp. : 1855-1860

Spandidos Publications

Access to resources Recommend Favorite

An Approach to the Design and Implementation of Clinical Trials of Empirical Antibiotic Therapy in Febrile and Neutropenic Cancer Patients

By Viscoli C.   Bruzzi P.   Glauser M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2013-2022

Elsevier

Access to resources Recommend Favorite